World Equity Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
World Equity Group's ABBV Position: Q3 2026 in Review
World Equity Group reduced its AbbVie (ABBV) stake by 36% in Q3 2026, selling an estimated $740K and leaving 5,088 shares worth $1.33M. The position accounts for 0.55% of the portfolio, ranked #37.
World Equity Group first reported a position in ABBV in Q1 2022 and has held it in 19 quarters since. The position peaked at $2.4M in Q1 2022. 1,120 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- World Equity Group held 5,088 shares of AbbVie worth $1.33M as of Q3 2026.
- World Equity Group sold 2,887 AbbVie shares in Q3 2026, an estimated $740K.
- AbbVie made up 0.55% of World Equity Group's portfolio in Q3 2026, its #37 holding.
- World Equity Group first reported a position in AbbVie in Q1 2022 and has held it in 19 quarters since.
- World Equity Group's AbbVie position peaked at $2.4M in Q1 2022.
- 1,120 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on World Equity Group's 13F filing for Q3 2026, filed 14 Oct 2026.